Fundamentals data is not available for this company.
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-25 | 3,215.70 | 1,559.36 | 2,768.04¢ | 14.6 | n/a | n/a | n/a | 0.0% |
31-Dec-26 | 3,385.89 | 1,622.17 | 2,863.37¢ | 14.1 | 4.1 | +3% | n/a | 0.0% |
31-Dec-27 | 3,555.02 | 1,652.88 | 2,808.36¢ | 14.4 | n/a | -2% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
GlaxoSmithKline reportedly running the ruler ove... | 04-Aug-2017 | ShareCast |
Contracting | 06-Dec-2007 | Washington Post |
United Therapeutics Shares Soar on FDA Report | 02-Nov-2007 | Washington Post |
Study Raises Questions For United Therapeutics | 27-Feb-2007 | Washington Post |
Currency | US Dollars |
Share Price | $ 405.02 |
Change Today | $ 0.18 |
% Change | 0.04 % |
52 Week High | $410.00 |
52 Week Low | $274.70 |
Volume | 626,423 |
Shares Issued | 43.56m |
Market Cap | $17,644m |
RiskGrade | 132 |
Strong Buy | 6 |
Buy | 4 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 15 |
Time | Volume / Share Price |
16:00 | 110 @ $405.13 |
16:00 | 85,285 @ $405.02 |
15:59 | 126 @ $404.98 |
15:59 | 153 @ $405.10 |
15:59 | 189 @ $405.10 |
You are here: research